Literature DB >> 11850485

Labeling of mixed leukocytes with (99m)Tc-HMPAO causes severe chromosomal aberrations in lymphocytes.

Ilknur Ak1, Erkan Vardereli, Beyhan Durak, Zafer Gülbaş, Nurettin Basaran, Marcel P M Stokkel, Ernest K J Pauwels.   

Abstract

UNLABELLED: 99mTc-d,1-hexamethylpropyleneamine oxime (HMPAO) is widely used as a labeling agent for leukocytes in the diagnosis of inflammatory or infectious foci. Cytotoxicity studies have indicated that intracellular labeling of leukocytes with (111)In compounds may have severe detrimental effects on the cells.
METHODS: In this study, the radiotoxic effects on mixed lymphocytes after labeling with (99m)Tc-HMPAO was investigated using the cytokinesis-blocked micronucleus assay and chromosomal aberration assay.
RESULTS: Whereas negligible numbers of chromosome abnormalities were noted in unlabeled lymphocytes, the labeled lymphocytes showed multiple aberrations of various types, including dicentric, tricentric, and fivecentric chromosomes; centric rings; chromosome and chromatid type breaks; and acentric fragments.
CONCLUSION: Heavily aberrant lymphocytes are seen in (99m)Tc-HMPAO-labeled mixed leukocytes after routine clinical procedures. It is unlikely, however, that this would cause detrimental effects, such as lymphoid malignancy, as these cells would normally be eliminated through apoptosis or phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850485

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine.

Authors:  Erik F J de Vries; Manel Roca; Francois Jamar; Ora Israel; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04       Impact factor: 9.236

2.  99mTc-HMPAO labelled white blood cell scintigraphy in patients with osteoarticular infection: the value of late images for diagnostic accuracy and interobserver reproducibility.

Authors:  P Fernandez; A Monet; C Matei; H De Clermont; M Guyot; R Jeandot; H Dutronc; C Dumoulin; M Dupon; D Ducassou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-27       Impact factor: 3.267

3.  Iodine-131 treatment and chromosomal damage: in vivo dose-effect relationship.

Authors:  Taner Erselcan; Selma Sungu; Semra Ozdemir; Bulent Turgut; Derya Dogan; Ozturk Ozdemir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-28       Impact factor: 9.236

4.  Non-radioactive and sensitive tracking of neutrophils towards inflammation using antibody functionalized magnetic particle imaging tracers.

Authors:  Prashant Chandrasekharan; K L Barry Fung; Xinyi Y Zhou; Weiwen Cui; Caylin Colson; David Mai; Kenneth Jeffris; Quincy Huynh; Chinmoy Saayujya; Leyla Kabuli; Benjamin Fellows; Yao Lu; Elaine Yu; Zhi Wei Tay; Bo Zheng; Lawrence Fong; Steven M Conolly
Journal:  Nanotheranostics       Date:  2021-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.